Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2009
10/06/2009USRE40930 Porcine adenovirus type 3 genome
10/06/2009US7598362 Hepatitis C virus vaccine
10/06/2009US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/06/2009US7598354 Campylobacter glycans and glycopeptides
10/06/2009US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
10/06/2009US7598272 Kinase inhibitors
10/06/2009US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
10/06/2009US7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
10/06/2009US7598253 Reverse-turn mimetics and methods relating thereto
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009US7598230 Nucleotide mimics and their prodrugs
10/06/2009US7598056 Factor VII or VIIA-like molecules
10/06/2009US7598027 Botulinum toxin screening assays
10/06/2009US7597893 Human monoclonal antibody specific lipopolysaccharides (LPS) of serotype IATS 06 of Pseudomonas aeruginosa
10/06/2009CA2616580C Macrocyclic inhibitors of hepatitis c virus
10/06/2009CA2513809C Lipophilic derivatives of double-stranded ribonucleic acid
10/06/2009CA2399971C Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
10/06/2009CA2368095C Process for preparing inhibitors of nucleoside metabolism
10/06/2009CA2328076C Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
10/06/2009CA2310888C Monoclonal human natural antibodies
10/06/2009CA2306224C Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions
10/02/2009CA2626292A1 Spray solution to treat athlete's foot
10/01/2009WO2009120914A1 Solid forms of an anti-hiv phosphoindole compound
10/01/2009WO2009120890A1 Dioxolane and dioxolanone fused indolobenzadiazepine hcv ns5b inhibitors
10/01/2009WO2009120841A1 Crystalline form of n-[[4-fluoro-2-(5-methyl-1h-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sodium salt monohydrate
10/01/2009WO2009120789A1 Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
10/01/2009WO2009120745A1 Compounds for the treatment of hepatitis c
10/01/2009WO2009120733A1 Pyrrolidine fused indolobenzadiazepine hcv ns5b inhibitors
10/01/2009WO2009120650A1 Aromatic heterocyclic fused indolobenzadiazepine hcv ns5b inhibitors
10/01/2009WO2009120358A1 Oligomer-nitrogenous base conjugates
10/01/2009WO2009120339A2 Vectors for delivering disease neutralizing agents
10/01/2009WO2009120306A1 Multivalent vaccine vector for the treatment and inhibition of viral infection
10/01/2009WO2009119794A1 Prophylactic/therapeutic agent for infectious disease
10/01/2009WO2009119792A1 GHRELIN AND DERIVATIVE THEREOF, OR THERAPEUTIC AGENT FOR CHRONIC RESPIRATORY TRACT INFECTIONS COMPRISING GROWTH HORMONE SECRETAGOGUE RECEPTOR 1a AGONIST AS ACTIVE INGREDIENT
10/01/2009WO2009119785A1 Method for purifying ethynylthymidine compound
10/01/2009WO2009119710A1 Novel antibiotic sf2896 substance, process for production thereof, and pharmaceutical composition
10/01/2009WO2009119667A1 Helicobacter pylori GROWTH INHIBITOR AND METHOD FOR PRODUCTION THEREOF
10/01/2009WO2009119167A1 Aniline derivative having anti-rna viral activity
10/01/2009WO2009118379A1 An antimicrobial composition
10/01/2009WO2009118324A1 5imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes
10/01/2009WO2009117985A1 Pirinixic acid derivatives as prostglandin e2 synthesis inhibitors for treating inflammatory diseases
10/01/2009WO2009117831A1 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
10/01/2009WO2009117829A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
10/01/2009WO2009094191A3 Methods of treating viral infections
10/01/2009WO2009094190A3 Methods of treating viral infections
10/01/2009WO2009077484A3 A cyano piperidinyl-phenil-oxazolidinone and use thereof.
10/01/2009WO2009067225A4 Boceprevir derivatives for the treatment of hcv infections
10/01/2009WO2009060835A8 Novel ubiquilin-binding small molecule
10/01/2009WO2009043987A9 Antibiotic compositions containing essential oils, prophylaxis and treatment of nosocomial diseases
10/01/2009WO2009033809A3 Use of a peptide as a therapeutic agent
10/01/2009WO2009033791A3 Use of a peptide as a therapeutic agent
10/01/2009WO2009033730A3 Peptide gxgrgdspca as a therapeutic agent
10/01/2009WO2009033666A3 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent
10/01/2009WO2008093280A8 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen
10/01/2009US20090247741 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/01/2009US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009US20090247643 Medicinal herbal composition for treating infection
10/01/2009US20090247639 Sulfonic acid and aldehyde condensation polymers for the treatment and prevention of hpv
10/01/2009US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
10/01/2009US20090247610 Integrase cofactor
10/01/2009US20090247607 dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION
10/01/2009US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
10/01/2009US20090247578 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
10/01/2009US20090247547 Hydroxamate-based inhibitors of deacetylases b
10/01/2009US20090247545 Substituted oxazolidinone derivatives
10/01/2009US20090247529 Topical compositions
10/01/2009US20090247523 Carboxamide 4-[(4-pyridyl)amino]pyrimidines useful as hcv inhibitors
10/01/2009US20090247516 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents
10/01/2009US20090247513 Benzothiophene compounds having antiinfective activity
10/01/2009US20090247512 Macrocylic inhibitors of hepatitis c virus
10/01/2009US20090247506 Antibacterial agents
10/01/2009US20090247487 Combination Therapy to Treat Hepatitis B Virus
10/01/2009US20090247470 Phenylalanine dipeptide derivatives, compositions and use thereof
10/01/2009US20090247458 Compositions and methods for treating cystic fibrosis
10/01/2009US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
10/01/2009US20090247455 Isolation of Inhibitors of IRES-Mediated Translation
10/01/2009US20090246855 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
10/01/2009US20090246827 Recombinant toxin fragments
10/01/2009US20090246292 Antimicrobial formulations comprising a quinone and a copper salt
10/01/2009US20090246280 Resin Powder Containing Aluminum Salt, Process for Production of the Same, and Resin Composition, Phosphorus Adsorbent, Antibacterial Agent or Antifungal Agent Comprising the Same
10/01/2009US20090246258 Antimicrobial and odor adsorbing textile
10/01/2009US20090246254 Non-hormonal vaginal contraceptive
10/01/2009US20090246228 Moraxella catarrhalis Proteins
10/01/2009US20090246227 Methods of use for hsv-1 and hsv-2 vaccines
10/01/2009US20090246226 Avian vaccines possessing a positive marker gene
10/01/2009US20090246225 Methods of Producing Influenza Vaccine Compositions
10/01/2009US20090246222 Live Attenuated Bordetella Strains as a Single Dose Vaccine Against Whooping cough
10/01/2009US20090246202 Human Endokine Alpha and Methods of Use
10/01/2009US20090246201 Substances
10/01/2009US20090246177 Megasphaera elsdenii strain and its uses
10/01/2009US20090246171 Automatic system for dose control in treating hepatitis c using infusion pumps
10/01/2009US20090246165 Disinfectant with Quarternary Ammonium Polymer and Copolymers
10/01/2009US20090246150 Antimicrobial composition
10/01/2009US20090246147 Delivery Of Antipsychotics Through An Inhalation Route
10/01/2009CA2756800A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
10/01/2009CA2719560A1 An antimicrobial composition
10/01/2009CA2719544A1 Novel substituted imidazoquinolines
10/01/2009CA2718608A1 Solid forms of an anti-hiv phosphoindole compound
10/01/2009CA2717948A1 5imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes
10/01/2009CA2712613A1 Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
1 ... 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 ... 1798